Nicholas Simon

Director/Board Member at

The J. David Gladstone Institutes

69 year

84 connections

Health Technology

Finance

Commercial Services

Profile

Nicholas Simon founded Clarus Ventures LLC in 2005, where he worked as Managing Director from 2005 to 2018 and Collabra Pharma, Inc. in 2000, where he worked as Chief Executive Officer & Director in 2000.
Mr. Simon also currently works at Rinat Neuroscience Corp., as Director, Nuvelution Pharma, Inc., as Director, MPM BioVentures III GP LP, as General Partner from 2001, The California Academy of Sciences, as Trustee from 2019, The J.
David Gladstone Institutes, as Trustee & Member, and Blackstone Life Sciences Advisors LLC, as Operating Partner from 2018.
Mr. Simon also formerly worked at Poniard Pharmaceuticals, Inc., as Independent Director from 2006 to 2012, SangStat Medical Corp., as Director, Avanir Pharmaceuticals, Inc., as Director from 2008 to 2010, InterMune, Inc., as Director, Rigel Pharmaceuticals, Inc., as Director, QuatRx Pharmaceuticals Co., as Director, Genitope Corp., as Director, Barrier Therapeutics, Inc., as Director from 2003 to 2007, CoTherix, Inc., as Director from 2003 to 2007, Proacta, Inc., as Director, Achillion Pharmaceuticals, Inc., as Independent Director from 2011 to 2012, Verus Pharmaceuticals, Inc., as Director, Neosil, Inc., as Director, Lycera Corp., as Director, Biovitrum AB, as Director, ARYx Therapeutics, Inc., as Director, Genteric, Inc., as Director, Project Sage Oldco, Inc., as Lead Independent Director from 2015 to 2021, Pearl Therapeutics, Inc., as Director, Gritstone bio, Inc., as Independent Director from 2015 to 2021, Genentech, Inc., as Vice President-Business & Corporate Development from 1989 to 2000, XOMA Royalty Corp., as Principal, and MPM BioImpact LLC, as General Partner from 2001 to 2005.
Mr. Simon received his Masters Business Admin degree from Loyola University of Chicago and undergraduate degree from the University of Maryland.

Nicholas Simon active positions

Companies	Position	Start
The J. David Gladstone Institutes The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology	Director/Board Member	-
MPM BioVentures III GP LP	Corporate Officer/Principal	2000-12-31
The California Academy of Sciences The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution	Director/Board Member	2019-09-24
Rinat Neuroscience Corp. Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases	Director/Board Member	-
Blackstone Life Sciences Advisors LLC Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions.	Private Equity Investor	2018-11-30

All active positions of Nicholas Simon

Former positions of Nicholas Simon

Companies	Position	End
PROJECT SAGE OLDCO, INC.	Chairman	-
GRITSTONE BIO, INC.	Director/Board Member	2021-05-31
SangStat Medical Corp. SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation	Director/Board Member	2019-11-03
Clarus Ventures LLC Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences.	Founder	2018-12-30
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Nicholas Simon's experience

Training of Nicholas Simon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicholas Simon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	33
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases	Health Technology
SangStat Medical Corp. SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation	Health Technology
XOMA Royalty Corp. XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics	Health Technology
Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder	Health Technology
InterMune, Inc. InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases	Health Technology
Rigel Pharmaceuticals, Inc. Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs	Health Technology
QuatRx Pharmaceuticals Co. QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutic compounds	Health Technology
MPM BioVentures III GP LP
Genitope Corp. Genitope Corp. BiotechnologyHealth Technology Develops immunotherapies for the treatment of cancer	Health Technology
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products in the field of dermatology	Health Technology
CoTherix, Inc. CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products	Health Technology
Proacta, Inc. Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer	Health Technology
Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases	Health Technology
Verus Pharmaceuticals, Inc. Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pediatric-oriented pharmaceutical products	Health Technology
Neosil, Inc. Neosil, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Lycera Corp. Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer	Health Technology
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Finance
Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services	Commercial Services
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Loyola University of Chicago Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Genteric, Inc. Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology	Health Technology
Rinat Neuroscience Corp. Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases	Health Technology
Clarus Ventures LLC Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences.	Finance
The California Academy of Sciences The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution	Commercial Services
Project Sage Oldco, Inc. Project Sage Oldco, Inc. Medical SpecialtiesHealth Technology Develops and sells medical aesthetics products	Health Technology
The J. David Gladstone Institutes The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology	Commercial Services
Pearl Therapeutics, Inc. Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases	Health Technology
Collabra Pharma, Inc.
Nuvelution Pharma, Inc. Nuvelution Pharma, Inc. BiotechnologyHealth Technology Provides solutions for R&D companies in the pharmaceutical and biotech industries	Health Technology
Gritstone bio, Inc. Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer	Health Technology
Blackstone Life Sciences Advisors LLC Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions.	Finance